A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer

Clinical trial NCT02901483 · TERMINATED

Trial details

NCT number: NCT02901483
Sponsor: PharmaEngine
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2016-10-11
Primary completion: 2020-08-17
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.